Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

✍ Scribed by David T. Felson; Jennifer J. Anderson; Mary L. M. Lange; George Wells; Michael P. LaValley

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 662 KB
• Volume: 41
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/1529-0131(199809)41:9<1564::aid-art6>3.0.co;2-m